2023 Partners

OmniAb logo

OmniAb

Program Partner

OmniAb’s discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence™ (BI) of our proprietary transgenic animals, including OmniRat®, OmniChicken® and OmniMouse® that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniFlic® (transgenic rat) and OmniClic® (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur™ features unique structural attributes of cow antibodies for complex targets. We believe the OmniAb animals comprise the most diverse host systems available in the industry and they are optimally leveraged through computational antigen design and immunization methods, paired with high-throughput single B cell phenotypic screening and mining of next-generation sequencing datasets with custom algorithms to identify fully human antibodies with superior performance and developability characteristics. These proprietary technologies are joined with and leverage OmniDeep™, which is a suite of in silico tools for therapeutic discovery and optimization that are woven throughout OmniAb’s various technologies and capabilities. Additionally, an established core competency focused on ion channels and transporters further differentiates OmniAb’s technology and creates opportunities in many emerging target classes. OmniAb antibodies have been leveraged across modalities, including bispecific antibodies, antibody-drug conjugates and others.

The OmniAb suite of technologies span from BI-powered repertoire generation to cutting edge antibody discovery and optimization offering a highly efficient and customizable end-to-end solution for the growing discovery needs of the global pharmaceutical industry.

For more information, please visit www.omniab.com

applied biomath logo

Applied BioMath

Program Partner

Applied BioMath applies biosimulation, including quantitative systems pharmacology, PKPD, bioinformatics, machine learning, clinical pharmacology, and software solutions to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk therapeutic research and development. Their approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through all phases of clinical trials. The Applied BioMath team leverages their expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their therapeutic, its best-in-class parameters, competitive advantages, patients, and the best path forward into and in the clinic.

www.appliedbiomath.com

Beacon_Final_RGB_COL

Beacon

Program Partner

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients. 

www.beacon-intelligence.com

380466b1-3626-43b3-bdc1-0c0f881ea3d9

Carterra

Program Partner

Carterra® is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra’s LSA® instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other label-free systems. .

www.carterra-bio.com

BSP logo

BSP Pharmaceuticals 

Branding Partner

BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & CNS among others, with a specific focus on innovative compounds as small and large molecules.

With full containment facility, applying the most advanced and safe technologies, BSP can offer a wide range of services for Pre-Clinical, Clinical and Commercial supply in compliance with the highest Quality requirements.

www.bsppharmaceuticals.com

896f885e-24ca-45fa-81cb-6ae50d739e0e

InSysBio

Innovation Partner

InSysBio is a company that provides a full range of mechanistic modeling services and tools. Having a long track record of disease modeling, our team helps pharmaceutical companies to make the right decisions at the critical stages of drug research and development in various therapeutic areas. InSysBio applies quantitative systems pharmacology modeling as well as PBPK and PK/RO/PD modeling approaches to predict optimal FIH dose, RP2D for mAbs, ADCs, bispecific and multi-specific antibodies.

www.insysbio.com

Nona Biosciences

Innovation Partner

Nona Biosciences is a Boston based Biotech company specialized in fully human therapeutic antibody technology. Our proprietary Harbour Mice® technology are fully human transgenic mice platforms for either conventional fully human antibody (H2L2) or heavy chain only (HCAb) antibody discovery, engineering, and development. The HCAb platform is fully optimized and clinically validated with global patented protection.

www.nonabio.com

Absolute Biotech logo

Absolute Biotech

Exhibition Partner


Absolute Biotech unites multiple antibody-centric brands to specialize in antibody reagents, kits and services. We offer a large reagent catalog, as well as antibody sequencing, engineering and recombinant expression services. Our engineering services include species and isotype switching, humanization, and developing antibody fragments, Fc fusion proteins and multispecific antibodies. To date, we have engineered and manufactured more than 180 antibody formats using our proprietary cloning system, including dozens of bispecific formats.

Visit www.absolutebiotech.com for more info.

SGScmykcoated30mm

SGS Vitrology

Exhibition Partner


SGS Vitrology (Glasgow): As a world leader in biopharmaceutical testing services, we offer you a comprehensive range of biologics safety testing, including virology, cell and molecular biology, as well as microbiology and electron microscopy. As a result, we can help you to ensure product safety and meet your regulatory requirements.

Visit Health Science | SGS for more info.

biolabs-logo

Creative Biolabs

Exhibition Partner

Technical advancement has always been a focus of Creative Biolabs, which, sustained by seasoned scientists and cutting-edge methodologies, provides technical support for global customers in the academic and industrial sectors with market-pioneering solutions especially for bispecific antibody (BsAb) discovery, covering BsAb antibody design, purification, engineering, analysis, as well as top-tier BsAb products such as appended IgGs, tandem scFv, bispecific IgGs, diabody, and minibody. Featured and exclusive platforms incorporating hybridoma, chemical conjugation, and genetic engineering are the driving force behind the success of assorted projects.

Visit www.creative-biolabs.com for more info

 

Fujifilm Diosynth Biotechnologies

Exhibition Partner

FUJIFILM Diosynth Biotechnologies is an industry-leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting the biopharmaceutical industry in the development and production of biologics, vaccines and cell and gene therapies.

Our focus is to combine technical leadership in process development and cGMP manufacturing supported by a strong team of over 4,000 employees and a reputation for excellent customer service. We are a trusted partner of many clients, from early stage biotechs to large pharma.

Our locations:

Watertown, MA

Research Triangle Park, NC

Holly Springs, NC, USA (coming in 2024)

College Station, TX

Hillerød, Denmark

Teesside, UK
Thousand Oaks, CA

www.fujifilmdiosynth.com

imaginab final logo

ImaginAb

Event Partner

ImaginAb is a clinical stage, revenue-generating global biotechnology company developing the next generation of imaging agents and radiopharmaceutical therapy (RPT) products through its proprietary minibody and cys-diabody platforms. The lead candidate 89Zr crefmirlimab berdoxam (CD8 ImmunoPETâ„¢) imaging agent is currently in Phase II clinical trials and has been licensed by numerous pharmaceutical and biotech companies for use in imaging within their immunotherapy clinical trials, primarily in oncology.

www.imaginab.com

nicoya

Nicoya

Event Partner

Nicoya is a Canadian biotechnology company specializing in innovative biosensor technology for the biopharmaceutical and academic sectors. In their mission to improve human life, Nicoya provides scientists with integrated and intuitive SPR solutions that accelerate discovery and characterization of biologics. Nicoya's benchtop instruments are now enabling hundreds of scientists in over 50 countries with best-in-class data for their life-changing research.

Visit www.nicoyalife.com for more info.